Andrew Chadwick-Jones
Partner in the Health & Life Sciences, Oliver Wyman

Andrew is leader of the Global Health Systems team and is based in Oliver Wyman’s London Office. He has been at the firm for 17 years and in that time has worked on over 150 client engagements.

His areas of focus include; innovation in new integrated care models and their adoption by providers and implications for payers, performance improvement in hospital systems, ranging from traditional cost reduction through to implementation of new care models, and public-private partnerships (often between new entrants and the NHS).

Prior to joining Oliver Wyman in 1995, Andrew won an exhibition scholarship at Christ Church, Oxford University, where he holds an BA and MA in Biological Sciences.

Zoe Bedford
Chief executive, ZPB

Zoe set up ZPB Ltd in August 2009 to help private, public and third sector organisations grow reach and influence in the health sector.

She directs many of ZPB’s strategic accounts and in the past year has led organisations through major crisis situations, helped reposition well-established brands within the health sector and launched several new organisations into the UK market.

Prior to ZPB, Zoe was head of marketing and communications at Dr Foster. During her tenure there, the company trebled in size.

Zoe regularly speaks on market access, health tech and how to forge successful cross-sector partnerships. She manages the Cambridge Health Network, is a Fellow of the RSA and a member of the Entrepreneurs’ Organisation (EO).

Gerald Dunstan
Principal in Health & Life Sciences, Oliver Wyman

Gerald Dunstan is a Principal in the Health & Life Sciences practice of Oliver Wyman, based in the London office.

He works across the pharma industry and the health system and his experience includes developing clinical engagement and market entry and access strategies, delivering large scale change programmes, and building operational improvement, leadership and communication capability across leading hospital trusts in the UK.

Gerald previously led the H&LS practice at KPMG and prior to that was an Associate Principal in McKinsey’s healthcare team. Gerald has a PhD in drug discovery awarded via the Glaxo Scholarship Scheme, an MBA (Distinction) from Warwick Business School and a BSc (Hons.) in Microbiology from the University of Surrey.

Christine Outram
Chair, The Christie NHS Foundation Trust

Chris has been Chair at The Christie NHS Foundation Trust in Manchester for two years, following on from a long career in the NHS at local, regional and national level, and as a chief executive for 20 years.

Previous posts include chief executive of Leeds Primary Care Trust, chief executive of North Central London Strategic Health Authority (SHA), and as acute operations director in London. She has also held several senior national posts, including establishing Medical Education England in 2009-11, leading the Department of Health’s review of arm’s length bodies in 2006-8, and more recently as Director of Intelligence and Strategy at NHS England. As SHA CEO she took the national lead on diversity and equality, and continues to champion passionately the cause of better inclusion of all staff and patients.

Kayleigh Hartigan
Managing Director, Marwood Group

Kayleigh is the Managing Director of Marwood Group's UK and European Healthcare Advisory practice where her main clients are institutional investors and cooperates.

Prior to setting up Marwood's European team, Kayleigh was a Senior Strategy Manager at NHS England working in the CEO's strategy unit, where she supported the development of a blueprint for new models of care.

Kayleigh started her career at the WHO and then joined the Department of Health where she played a critical role in a range of policy work, including: drafting the Health and Social Care Act 2012 and reform of social care financing in England. Kayleigh received her Master's in Health, Policy Planning, and Financing from LSE and her Bachelors from UCL.

Chris Streather
Chief Medical Officer, HCA Healthcare UK

Chris is a renal physician by training. He was appointed to St George’s as a Consultant in 1997. He became Medical Director in 2004, later Director of Strategy and worked on the National Physicians Assistant pilot, the RCP Acute Medicine Task Force and Lord Ara Darzi’s Framework for Action.

He was the London Clinical Director in 2008 when London’s Stroke services were being comprehensively redesigned and worked on the Primary and Community Care Advisory Board of the NHS Next Stage Review. From 2009 - 2012 he was the first CEO of South London Healthcare, and from 2012 - 2015 the Managing Director of the Health Innovation Network, leading for the Networks Nationally on Patient Safety. He was an Academic Health Science Network (AHSN) representative on the National Institute for Health and Care and Excellence (NICE) Implementation Collaborative and the Ministerial Medical Technologies Strategy Group. He is a senior independent director at Kingston Hospital NHS Foundation Trust.

Crispin Ellison
Partner, Health and Life Sciences and Public Policy, Oliver Wyman

Crispin Ellison advises senior government and health decision-makers on policy, strategy, performance improvement and cost reduction. He is deeply connected with top government and parliamentary decision makers in the UK, the EU and the Middle East. His clients include central government departments the UK, EU commissioners and their teams, the UK National Health Service and GCC governments.

He has recently worked with the UK Prime Minister’s office to identify new care models for health and community care to deliver significant improvements in the quality of healthcare and patient experience whilst saving some 15% costs per annum. The work drew on best practice innovation in both public and private sectors globally, as well as lessons learned in implementing major changes.

Crispin also supported the UK Cabinet Office in their assessment of cross government back office efficiency, including HR, IT, Finance, Procurement, consultancy/contactor management, property highlighting his in depth knowledge of the system.

Alex Kafetz
Chief Operating Officer, ZPB

Alex is chief operating officer at ZPB with responsibility for leading the data projects. A strong advocate of the publication of information to improve healthcare performance, Alex gave evidence to the public inquiry into Mid Staffordshire Hospitals NHS Foundation Trust, is a member of the National Information Board, the DH Transparency Programme Board and the Waltham Forest CCG Patient Participation Board.

Alex joined from Dr Foster where he was head of strategic insight. He has edited six editions of the Hospital Guide (two with Zoe Bedford) and produced two instalments of the influential Intelligent Board series. He was also a key part of the teams that conceived and launched NHS Choices and Dr Foster’s pioneering Global Comparators programme.

After beginning his career in the NHS, Alex spent six years in regulation latterly at the Healthcare Commission leading on elements of the annual health check including risk based inspection targeting and presentation of information.

In 2006/07 Alex was an inaugural winner of the James Mayes award and spent time working for leading US healthcare company Premier Inc.

Jake Arnold Foster
Chief executive, Carradale

Jake has been involved in healthcare for over 20 years. He is an entrepreneur, consultant, non-executive board member, founder and Executive Chairman of COBIC Ltd and a former Chief Executive. Through his consultancy Carradale, Jake works with a variety of organisations from both the private and public sector, linking them together allowing them to maximise each other’s potential. Jake manages and advises companies using expertise and experience from the industry and through this has developed a broad network of chief executives, policy makers, civil servants, professionals and managers across the private, public and voluntary sector both in the UK and internationally.

He has a strong track record in organic growth in revenues and profits and extensive experience in new product development, sales and market development and team creation and leadership and a deep knowledge of health and public sector information, technology and media markets. His consulting expertise brings with it networks and networking skills with a hands on understanding of governance requirements of public, private and voluntary sectors.

Pam Garside
Chief executive, Newhealth

Pam Garside has her own management consultancy, Newhealth, specialising in organisational strategy and development in health care, and is a Fellow of the Judge Business School of the University of Cambridge. She works extensively with boards of a wide range of health care organisations on strategy, governance and leadership issues and advises new entrants to the UK health market including digital and start up companies. Pam founded and co-chairs The Cambridge Health Network, a membership group of senior players in UK health, both private and public sector, and is a board member of Whizz-Kidz charity and ZPB Ltd. She is a member of the Investment Committee of Cambridge Enterprise, the technology transfer company of the University of Cambridge and Senior Adviser to Smith Square Partners. She also sits on a number of advisory boards and is an angel investor.

Pam began her professional life in management in the NHS and subsequently spent many years studying and working internationally based in the USA. She holds a BSc from the University of Durham and a Masters Degree in Hospital and Health Care Administration from the University of Minnesota. She is an Adjunct Professor at Imperial College Business School.

Andrew Taylor
Partner, Aldwych Partners

Prior to joining Aldwych Partners, Andrew was the inaugural Director of the Cooperation and Competition Panel (CCP), now part of Monitor. While at the CCP, Andrew reviewed numerous mergers, competition complaints and procurement disputes, and developed the methodologies now used by Monitor to assess anti-competitive behaviour and merger benefits.

Andrew has also been Senior Director, Inquiries at the UK Competition Commission where he led numerous merger and market investigations, and more recently, he managed several business units for the European business of McKesson, a US healthcare IT firm.

Site visits

Participants will get the chance to visit two leading hospitals in the north west of England, choosing from a combination of general actute hospitals, specialist NHS care and private healthcare.

The Christie NHS Foundation Trust
www.christie.nhs.uk

The Christie is one of Europe's leading cancer centres, treating over 44,000 patients a year.

They serve a population of 3.2 million across and as a national specialist around 26% of patients are referred to them from other parts of the country. They provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 10 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. They are also an international leader in research, with world first breakthroughs for over 100 years.

The Manchester Institute of Health & Performance

HCA Healthcare UK are an internationally recognised provider of private healthcare that specialise in complex and acute medical conditions.

The Manchester Institute of Health & Performance has been created to deliver excellence in every area of sports science and medicine.

The facility is funded by Manchester City Council, Sport England and City Football Group and is operated by HCA Healthcare UK.

This pioneering facility provides an environment that supports the professional development of experienced and up-and-coming athletes, whilst a dedicated educational facility promotes the health benefits of physical activity and fitness in the everyday lives of the community.